The presence of intratumoral microbes and their impact on tumor evolution have gained attention, offering new avenues for cancer treatment.[84] Cancers with prevalent KRAS mutations, such as those in the digestive tract, lungs, and melanomas, tended to show enriched microbial communities.[2, 84] Compared to their wild‐type counterparts, KRAS‐mutated tumors exhibited distinct microbial landscapes. The gene discussed is KRAS; the disease is cancer.